Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis.

Stem Cell Res Ther · 2019 · PMC6544951 · PMID 31151406

Europe PMC DOI

hedged sentence

0.1430

closest p · 2.9× alpha

0.1430

boldest claim

The sentences

showed a trendp = 0.143not close (p > 0.1)

The overall rate of death showed a trend of reduction of 36% (RR [CI] = 0.64 [0.35, 1.16], p = 0.143) in the MSC treatment group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.